Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC Meeting Abstract
| Authors: | Ma, B. B. Y.; Rudin, C. M.; Cervantes, A.; Dowlati, A.; Costa, D.; Schmid, P.; Heist, R.; Villaflor, V. M.; Sarkar, I.; Huseni, M. A.; Foster, P.; O'Hear, C.; Gettinger, S.; Besse, B. |
| Abstract Title: | Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC |
| Meeting Title: | ESMO Asia 2017 Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2016 Dec 16-19 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-12-01 |
| Language: | English |
| ACCESSION: | WOS:000393980600440 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdw594.005 |
| Notes: | Meeting Abstract: 441O -- Appears on page ix141 of the abstract book -- Source: Wos |
